Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • 3 top hospitals held...

    3 top hospitals held guilty of reusing Angio Balloon Catheters

    Written by Ruby Khatun Khatun Published On 2017-04-27T15:14:47+05:30  |  Updated On 27 April 2017 3:14 PM IST
    3 top hospitals held guilty of reusing Angio Balloon Catheters

    Mumbai: The Food and Drugs Administration (FDA) in a recent inspection found that three city hospitals including Fortis’s hospitals in Mulund, Hiranandani Hospital, Vashi and BSES Hospital, Andheri were guilty of not only overcharging patients for medical devices but also reusing catheters meant for single use on 72 patients, and charging them for the same. The FDA has issued show-cause notices to all the three hospitals for reusing balloon catheters meant for single use in angioplasty on multiple patients and thereby violating the Drug and Cosmetics Act.


    While speaking with TOI, Dr Harshdeep Kamble, FDA commissioner said "Based on information of recycling and reuse of medical devices on multiple patients, the FDA 's intelligence branch carried out an investigation between March 29 and April 1."


    “We visited four hospitals, and were shocked to see that among these, both Fortis hospitals were reusing balloon catheters, and charging patients for the same,” said Harshadeep Kamble, state FDA commissioner. He said that it was distressing to find that reputed hospitals such as Fortis were putting patients’ lives in danger with their unethical practices.


    He also added "These hospitals reused devices without taking consent or without giving prior information to patients."


    The modus operandi according to the officials was that the devices were, after single use, sent to the pharmacy for charging on the inpatient bill. "Later, these devices were sent to the central sterile supply department where they were cleaned and sterilized using ethylene oxide," they said. FDA’s investigations revealed that Fortis hospital, in Mulund, reused balloon catheters on 45 patients, and in Vashi catheters were reused on 27 patients while BSES Hospital, Andheri, had re-used 95 of these devices for 69 patients.


    They also discovered that both hospitals were also overcharging patients to the tune of Rs 15,000. (A balloon catheter costs around Rs 10,000, while the hospitals were charging anywhere between Rs 22,000 to Rs 25,000).


    “They were making a tidy profit,” said Kamble. As per medical guidelines, used catheters are to be disposed of. They cannot be sterilized and reused on patients. The FDA also found that there was no proper storage facility for the catheters at both Mulund and Vashi. “Under the Drugs and Cosmetics act, a catheter should be stored properly, but there, they were lying in the open,” said Kamble. The FDA said BSES Hospital was guilty of reusing the catheters, they had not charged their patients, most of who are from the underprivileged sections, any money for the catheters.

    According to the hospital, reusing catheters was an accepted practice across the world. “Anything that can be sterilized can be reused provided all care has been taken. Also, we are a charitable hospital, and a large number of our patients are poor, and since they cannot afford a new catheter, we have to reuse the device,” said Dr Ashok Mehta, a medical director at the hospital.

    “We have received a notice from Food and Drug Administration. We will evaluate the observations shared, and will respond appropriately,” said Fortis in a statement. Efforts to reach BSES failed. FDA officials said the hospitals have stopped re-use since the raids.

    Angio balloon cathetersBSES HospitalDr Harshdeep KambleFDAFortisFortis mulundGuiltyHiranandani HospitalThe Food and Drugs Administration
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok